Skip to content
MarketScale
‹ Back to IndustriesHealthcare

CBD and the Vending Industry: A Match Made in Heaven?

Imagine this: you go to an airport or train station. You are walking past rows of vending machines full of snacks and healthy prepared meals – then you stumble upon a smart vending machine full of CBD products. This is the future. This is now. As the CBD market scales, it’s expected to reach $24.4…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
CBD and the Vending Industry: A Match Made in Heaven?

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Imagine this: you go to an airport or train station. You are walking past rows of vending machines full of snacks and healthy prepared meals – then you stumble upon a smart vending machine full of CBD products. This is the future. This is now.

As the CBD market scales, it’s expected to reach $24.4 billion by 2025, according to CBD insights firm Brightfield Group and its 2019 report. While FDA regulations across the country gain steam, some states already have CBD and marijuana laws in place. CBD is legal in the United States. Having a CBD vending machine will depend on state and local laws, but the possibilities are growing.

CBD And Smart Vending Machines

In 2014, a marijuana dispensary in Vancouver launched what is thought to be the first marijuana/CBD vending machine. Since then, vending options have become more popular, and they are already popping up in Colorado, where recreational marijuana is legal.

Vending machines are also becoming more popular, in general. Intelligent vending machines, in particular, are ever-increasing in airports, bus stations and railroad stations. These hubs are now focusing on more automation, which means smart vending options will be the norm.

CBD products are primed to sell from vending machines. C-stores see these products flying off the shelf. The gummies and tinctures are low-hanging fruit, accounting for 50% of retail sales, according to IRI’s fourth-quarter 2019 CBD data report. Consumers grab the accessible products, so putting them in a vending machine will make them more enticing. Other products, such as CBD sparkling water, can easily be vended, consumed and enjoyed by consumers.

Vendor operators must be in compliance, though. So, make sure you’re abreast of local regulations and that there’s an age verification process in place.

Age Verification on CBD Vending Machines

Using smart vending machines, consumers will be able to buy a slew of CBD products ranging from edibles and oils to tinctures. But one thing the vending machines must do is have some age-verification technology in place. There is a plethora of options out there, with the SandenVendo V21i standing out amongst the best.

There are age restrictions for CBD products, so selling CBD out of a vending solution that can verify age is crucial.

One of the main features of these CBD vending machines will be the age-verification process. The V21i allows for age verification through an app, so, when users are in a transportation hub, they can use their smartphone to purchase CBD products from the vending machine. This intuitive, interactive and inclusive vending machine has a 21.5-inch touch screen, which will help make selecting products easier. The screen will allow for extra information to be available about each CBD product, so the consumer understands what they are buying. They can also pay with their digital wallet on their smartphone or watch.

Contact us today to learn more about the V21i and its age-verified, CBD vending capabilities.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

July partnerships show hospitals aligning without ownership change

July partnerships show hospitals aligning without ownership change

A July McDermott Will & Schulte analysis and four July partnership announcements tracked by Becker’s Hospital Review point to affiliation models that stop short of mergers. St. Christopher’s signed a nonbinding letter of intent with Nemours, Jefferson and Temple; Palomar UC San Diego Health began operating July 1 under a joint powers authority. Several announcements explicitly rule out ownership change, shifting the work to contracts covering governance and other terms.

  • 01In an alliance, the contract does the integrating that an org chart does in a merger: McDermott Will & Schulte says governance design, exclusivity, antitrust review, community commitments and exit rights all have to be settled before signing.
  • 02Purchasing is now explicitly on the table in at least one no-ownership deal, the St. Peter's Health and Billings Clinic-Logan Health talks in Montana, which means shared supply contracts can arrive without a change of control.

Sep 19, 2026

Eye telemedicine hits limits without home retinal imaging

Eye telemedicine hits limits without home retinal imaging

An Ophthalmology Times commentary by T.Y. Alvin Liu, Ferdinand Hui and Phillip Phan sorts eye patients into three telemedicine tiers by clinical need. Patients needing regular OCT scans benefit less unless a home device can send the image. Video tools already sit inside Epic and Cerner; the deciding purchase for retina clinics is the imaging device in the patient's living room.

  • 01The dividing line for eye telemedicine is imaging, not video: patients who need regular OCT scans benefit less from remote visits unless a device at home can send the scan, so a video license alone shifts few of those encounters.
  • 02The provider-side requirement, a HIPAA-compliant secured video platform, was already built into Epic and Cerner by 2020; the patient-side requirements (1.5 MB up and down bandwidth, a quiet private room, comfort with the technology) sit outside the health system's control and are the ones worth screening for at scheduling.
  • 03Self-administered home color fundus photography for tracking non-proliferative diabetic retinopathy was named as the nearer route into retina telemedicine; home OCT for wet AMD is the harder gate and the device to watch.

Sep 19, 2026

Value-based care reaches a quarter of revenue at 30% of surveyed health organizations

Value-based care reaches a quarter of revenue at 30% of surveyed health organizations

Wolters Kluwer Health argues value-based care software is judged on whether customers hit incentive thresholds and avoid penalties. A Fierce Healthcare-reported survey it cites puts value-based care at a quarter or more of revenue for 30% of organizations. The analysis is a vendor publication that ends by pitching its own UpToDate Connect API.

  • 01The sharper question for any population health or care coordination platform is whether it changes what a clinician does at the moment of decision, or only reports afterward what happened. Wolters Kluwer's reading of the evidence is that many platforms still struggle with the first.
  • 02Vendors selling into value-based contracts now face a build-or-license decision on clinical content, because Wolters Kluwer names current, trusted content, consistent clinician adoption across sites, and a traceable link from guidance to quality metrics as the three hard problems.

Sep 18, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512